Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Corentec Co., Ltd. (104540:KRX), powered by AI.
Corentec Co., Ltd. is currently trading at ₩4,255. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Corentec Co., Ltd. on Alpha Lenz.
Corentec Co., Ltd.'s P/E ratio is 8.9.
“Corentec Co., Ltd. trades at a P/E of 8.9 (undervalued) with solid ROE of 8.3%. 3Y revenue CAGR of 16.3% highlights clear growth momentum.”
Ask for details →Corentec Co., Ltd. is a specialized manufacturer engaged in the development and production of orthopaedic devices. The company's primary function revolves around improving the quality of life for individuals through its innovative medical solutions, specifically in the field of joint replacements. Corentec focuses on products such as hip and knee replacement systems, which are critical in the orthopedic surgical sector. These systems are designed to offer enhanced mobility and comfort for patients requiring joint reconstruction. The company operates in a sector that significantly impacts the healthcare industry, particularly addressing the needs of an aging global population, which is driving demand for orthopaedic solutions. Corentec Co., Ltd. is pivotal in the medical devices market, contributing to advancements in patient care and rehabilitation. By continuously investing in research and development, Corentec not only supports healthcare professionals in their practices but also enhances surgical outcomes and patient satisfaction.
“Corentec Co., Ltd. trades at a P/E of 8.9 (undervalued) with solid ROE of 8.3%. 3Y revenue CAGR of 16.3% highlights clear growth momentum.”
Ask for details →Corentec Co., Ltd. (ticker: 104540) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 170 employees. Market cap is $55.7B.
The current price is ₩4,255 with a P/E ratio of 8.9x and P/B of 0.71x.
ROE is 8.33% and operating margin is 9.26%. Annual revenue is $100.4B.